The oral protein-kinase C β inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.
Saved in:
| Title: | The oral protein-kinase C β inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines. |
|---|---|
| Authors: | Neri, Antonino1,2 (AUTHOR), Marmiroli, Sandra3 (AUTHOR), Tassone, Pierfrancesco4 (AUTHOR), Lombardi, Luigia1 (AUTHOR), Nobili, Lucia2 (AUTHOR), Verdelli, Donata1 (AUTHOR), Civallero, Monica5 (AUTHOR), Cosenza, Maria5 (AUTHOR), Bertacchini, Jessika3 (AUTHOR), Federico, Massimo5 (AUTHOR), De Pol, Anto3 (AUTHOR), Deliliers, Giorgio Lambertenghi2 (AUTHOR), Sacchi, Stefano5 (AUTHOR) lbsacchi@unimo.it |
| Source: | Leukemia & Lymphoma. Jul2008, Vol. 49 Issue 7, p1374-1383. 10p. 2 Black and White Photographs, 3 Charts, 3 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
